Dolby Laboratories (DLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2003 | |
| Sales | 217,472 |
| Cost of Goods | 73,643 |
| Gross Profit | 143,829 |
| Operating Expenses | 96,805 |
| Operating Income | 47,667 |
| Interest Expense | 2,292 |
| Other Income | 2,235 |
| Pre-tax Income | 47,610 |
| Income Tax | 16,079 |
| Net Income Continuous | 30,969 |
| Net Income | $30,969 |
| EPS Basic Total Ops | 0.36 |
| EPS Basic Continuous Ops | 0.36 |
| EPS Diluted Total Ops | 0.36 |
| EPS Diluted Continuous Ops | 0.36 |
| EBITDA(a) | $55,165 |